Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study

BACKGROUND: Omalizumab may modulate airway remodeling in severe asthma. Using forced expiratory volume in 1 second (FEV(1)) as a surrogate of airway remodeling, we aimed to investigate if an omalizumab add-on in severe allergic asthma may lead to a persistent reversal of airway obstruction and to ev...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Respir Dis
Egile Nagusiak: Solidoro, Paolo, Patrucco, Filippo, de Blasio, Francesca, Brussino, Luisa, Bellocchia, Michela, Dassetto, Davide, Pivetta, Emanuele, Riccio, Annamaria, Heffler, Enrico, Canonica, Walter, Rolla, Giovanni, Bucca, Caterina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6475845/
https://ncbi.nlm.nih.gov/pubmed/31002021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619841274
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak